Objectives: To examine baseline hormonal concentrations and the pharmacokinetic response on day 0 and day 28 of 28 days of androstenedione supplementation. Methods: Eight men (mean (SD) age 44.1 (3.0) ...

Androstenedione can also increase the risk of breast cancer and endometrial cancer. Among children and teens, androstenedione can put them at risk for the same hormonal effects as adults ...

(Nature Foods) Investigational atumelnant, a once-daily oral adrenocorticotropic hormone receptor antagonist, significantly reduced morning androstenedione ... positive breast cancer, said Bayer.